BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38602754)

  • 21. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
    Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
    Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
    Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
    Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to Pick Out the "Unreal" Gleason 3 + 3 Patients: A Nomogram for More Precise Active Surveillance Protocol in Low-Risk Prostate Cancer in a Chinese Population.
    Qi F; Zhu K; Cheng Y; Hua L; Cheng G
    J Invest Surg; 2021 Jun; 34(6):583-589. PubMed ID: 31588824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.
    Isharwal S; Miller MC; Epstein JI; Mangold LA; Humphreys E; Partin AW; Veltri RW
    Urology; 2009 May; 73(5):1092-7. PubMed ID: 19193410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors of ISUP Modified Gleason score upgrading after radical prostatectomy].
    Li XD; Qu GY; Xu N; Xue XY; Wei Y; Zheng QS; Li JF; Cai H; Lin YZ
    Zhonghua Nan Ke Xue; 2016 May; 22(5):415-9. PubMed ID: 27416665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.
    Gondo T; Poon BY; Matsumoto K; Bernstein M; Sjoberg DD; Eastham JA
    BJU Int; 2015 Jan; 115(1):81-6. PubMed ID: 24725760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
    Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
    [No Abstract]   [Full Text] [Related]  

  • 32. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.
    Carlsson S; Maschino A; Schröder F; Bangma C; Steyerberg EW; van der Kwast T; van Leenders G; Vickers A; Lilja H; Roobol MJ
    Eur Urol; 2013 Nov; 64(5):693-9. PubMed ID: 23683475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV; Sanderson H; Partin AW; Epstein JI
    J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new nomogram to predict pathologic outcome following radical prostatectomy.
    Crippa A; Srougi M; Dall'Oglio MF; Antunes AA; Leite KR; Nesrallah LJ; Ortiz V
    Int Braz J Urol; 2006; 32(2):155-64. PubMed ID: 16650292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic resonance imaging.
    Martini A; Gupta A; Cumarasamy S; Lewis SC; Haines KG; Briganti A; Montorsi F; Tewari AK
    Int J Urol; 2019 Apr; 26(4):458-464. PubMed ID: 30659663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive model of early urinary continence recovery based on prostate gland MRI parameters after laparoscopic radical prostatectomy].
    Mao H; Zhang F; Zhang ZY; Yan Y; Hao YC; Huang Y; Ma LL; Chu HL; Zhang SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):818-824. PubMed ID: 37807734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6.
    Mehta V; Rycyna K; Baesens BM; Barkan GA; Paner GP; Flanigan RC; Wojcik EM; Venkataraman G
    Int J Clin Exp Pathol; 2012; 5(6):496-502. PubMed ID: 22949931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
    Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L
    Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.